Cancer Survivor Empowerment Through the Use of Patient-Reported Outcomes: A Quantitative Study.
To assess whether the use of patient-reported outcomes (PROs) is associated with patient empowerment (PE) in cancer survivors in early survivorship.
A convenience sample of 83 adult cancer survivors participated in a quantitative repeated-measures study at a community-based cancer center, and 33 participants who received chemotherapy as the last treatment modality of their primary cancer treatment completed a questionnaire immediately following treatment and at three months.
Participants were recruited from the medical oncology clinic by oncology nurse research assistants and completed an electronic or paper survey composed of three instruments.
A significant relationship was found between PE and self-efficacy, and a significant negative correlation was observed between self-efficacy and symptoms. PRO self-efficacy predicted PE following chemotherapy treatment. PE decreased at three months post-treatment.
Clinician-driven assessment is less sustainable in survivorship care. The use of PROs for symptoms and self-efficacy is related to PE. A qualitative study for conceptual clarification of PE in cancer survivors is needed. Oncology nurses are key to envisioning how to implement survivor-reported symptom assessment that builds empowerment.
A convenience sample of 83 adult cancer survivors participated in a quantitative repeated-measures study at a community-based cancer center, and 33 participants who received chemotherapy as the last treatment modality of their primary cancer treatment completed a questionnaire immediately following treatment and at three months.
Participants were recruited from the medical oncology clinic by oncology nurse research assistants and completed an electronic or paper survey composed of three instruments.
A significant relationship was found between PE and self-efficacy, and a significant negative correlation was observed between self-efficacy and symptoms. PRO self-efficacy predicted PE following chemotherapy treatment. PE decreased at three months post-treatment.
Clinician-driven assessment is less sustainable in survivorship care. The use of PROs for symptoms and self-efficacy is related to PE. A qualitative study for conceptual clarification of PE in cancer survivors is needed. Oncology nurses are key to envisioning how to implement survivor-reported symptom assessment that builds empowerment.